Julie Conti retweeted
Excited to be a co-author of our new JAMA study using Epic Cosmos data from 5.2M newborns! Vitamin K refusal has doubled, with a 2.4x higher risk of intracranial bleeding. Hopefully these findings help clinicians counsel families.
📰 jamanetwork.com/journals/jam…
Julie Conti retweeted
📊 Among preterm infants with severe #RetinopathyOfPrematurity, #Dexamethasone eye drops numerically reduced progression to treatment-requiring type 1 disease without clinically significant differences in adverse events vs placebo. ja.ma/4zjgx6v
Coming back home after a great weekend at @PASMeeting Happy to have been able to present my work on defining growth failure in very low birth weight infants #PAS26selfie
2
81
We are enjoying our time at @PASMeeting! So much inspiring research and many ideas to take home to Vancouver #PAS26Selfie #PAS2026
69
We made it to #PAS2026 #PAS26selfie for a weekend of networking and learning!
1
87
Julie Conti retweeted
Ways to reinvigorate the physical exam in medicine
Step 1. Do the exam. No "WNL"—we never looked
nejm.org/doi/full/10.1056/NE…
Julie Conti retweeted
2D or M-mode can be used for measurement of LA:Ao ratio in extreme preterm infants #newpublication @Ped_Research @souvik_neo @E2i_BCCHR @NeoHemodynamics nature.com/articles/s41390-0…
Julie Conti retweeted
Take a look at the new Fenton Growth Charts against the old ones.📈 The difference in these curves tells an important story.
👀Dive into the discussion in this episode of The Journal Club: buff.ly/XQqc6jf
#FentonGrowthCharts #TheIncubator #Neonatology #TheJournalClub
Julie Conti retweeted
Octopus locomotion 🐙
We believe this warty deep-sea octopus to be in the Graneledone genus of octopuses, and ROV pilots collected this footage in the #MarDelPlataCanyon in Argentina, where researchers are exploring & documenting biodiversity.
Julie Conti retweeted
This #WorldBreastfeedingWeek, celebrate the powerful benefits of breastfeeding
Breast milk is all a baby needs for the 1st 6 mths
✅ ⬇️ newborn mortality
✅ Provides the perfect balance of nutrients
✅ Strengthens immunity against illnesses
✅ Reduces risk of obesity
#WHOFides
Julie Conti retweeted
“I remember taking my final exam, getting stuck on an answer, and thinking: ‘Who cares, I’m about to die.’ I knew something was very wrong. Medical school is always tiring, but this was a different kind of tired. I was getting by on multiple cups of coffee, multiple energy drinks. Large lumps had begun to appear in my neck. After the exam I stumbled down the hall to the ER and the doctors told me that my organs were failing. It took eleven weeks to make a diagnosis: a rare disease called Castleman’s. But there was no cure. A priest read me my last rites. I said goodbye to my family and prepared to die. But a last-minute dose of chemotherapy saved my life. Over the next year I relapsed three times. Each one almost killed me. The last was the worst: I spent a month in the ICU, and it took seven different chemotherapies to bring me back. By then I’d reached the maximum dose of chemo a human can tolerate. The doctors told me I was out of options, and the next relapse would certainly kill me. I only had one hope. A tiny hope, but a hope. I had to cure the disease myself. It takes a billion dollars and ten years to create a new drug; I didn’t have the money or time. My only chance was to discover an existing drug that would work. I made spreadsheets of every similar disease and every drug used to treat it. I wrote over 2000 emails to every doctor who’d published a paper on Castleman’s. I started studying samples of my own blood, but I ran out of time. Another relapse put me back in the ICU; from my hospital bed I asked the doctor to cut out one of my lymph nodes. I took it to the lab and discovered a particular protein called mTOR that was sending my immune system into overdrive. And that’s when I knew. I knew from my research that a drug called Sirolimus inhibits mTOR. My doctor was hesitant to prescribe it; there was no research to support my theory. But he took a chance, and within days my symptoms began to disappear. I still take the pill every day, eleven years later. I was able to marry my wife and have two beautiful kids. And through my work I’ve been able to save thousands of lives, by repurposing fourteen different drugs to treat rare diseases.”
---------------
Epilogue:
In 2022, @DavidFajgenbaum co-founded Every Cure, a nonprofit organization on a mission to save and improve lives by repurposing existing medicines to treat devastating diseases. While many drugs could be repurposed to treat many more diseases than they were intended to treat, there are no incentives in our current system to unlock these additional uses. Every Cure utilizes an AI platform to identify the most promising new uses for existing medicines for further laboratory research and clinical trials and works to get these treatments to all of the patients who can benefit. They have already launched 8 drug repurposing programs, including injection of the numbing medicine lidocaine for breast cancer and the vitamin derivative leucovorin for a subgroup of children with autism spectrum disorder who have anti-folate receptor antibodies.
Julie Conti retweeted
Necesitamos muchos más Santis de los que tenemos. Santi Demarco y @santikorovsky, mano a mano.
Julie Conti retweeted
¡Muchísimas gracias Monumento Nacional a la Bandera en #Rosario por izar la bandera de Canadá en ocasión del #DíaDeCanadá! #EstrechosLazos 🇨🇦🇦🇷
Julie Conti retweeted
One of the few programs in the country where you have dedicated TnEcho learning blocks throughout the fellowship
Pleased to share that we are inviting applications for @UBC Neonatal Hemodynamics and Targeted Neonatal Echocardiography (NHTNE) Subspecialty Fellowship training program starting July 2026
@NeoHemodynamics @AAPneonatal @CanPaedSociety @NeoHeartSociety @BCWomensHosp @nicupodcast
Julie Conti retweeted
Pleased to share that we are inviting applications for @UBC Neonatal Hemodynamics and Targeted Neonatal Echocardiography (NHTNE) Subspecialty Fellowship training program starting July 2026
@NeoHemodynamics @AAPneonatal @CanPaedSociety @NeoHeartSociety @BCWomensHosp @nicupodcast
Julie Conti retweeted
Ergonomics of Neonatal Chest Compressions. Some @EBNEO from my friend @drbirju and colleagues @Okla_Childrens Standard vs custom bed height. Do adjust the bed height ⬇️. Especially you short people. You know who you are. thieme-connect.de/products/e… @nicupodcast
Julie Conti retweeted
When we see parents doing kangaroo care, we should sincerely thank them as this simple act is saving lives!
New SRMA published in @LancetChildAdol confirms this intervention as high quality evidence in reducing death thelancet.com/journals/lanch…
@EBNEO @ESPR_ESN @nicupodcast
Julie Conti retweeted
Late preterm infants are the least likely to receive their mother’s own milk at 12 weeks, even less than extremely preterm babies, highlighting a critical gap in breastfeeding support for this vulnerable group. Improving milk provision in late preterm infants could positively impact their short- and long-term health outcomes. Learn more about this and other neonatal care insights by listening to the latest episode of The Incubator podcast.
buff.ly/zZu01dZ
Julie Conti retweeted
Excellent summary by @BCWomensHosp NICU fellow Kia Anarna on the @CochraneNeonate update on early ESA (Epo & Darbe) in preterm infants!
#PAS2025 @PASMeeting




























